Abstract
During the last two decades there has been an increasing interest in cardiac resynchronization therapy (CRT) in patients with heart failure. Major randomized clinical trials which tested the effectiveness of CRT included patients based on electrocardiographic (ECG) criteria amongst other features. However, there is an assumption that mechanical synchrony, as may be assessed by echocardiography, is the underlying mechanism that improves left ventricular function and finally the clinical outcome. Large multi-centre trials have failed to prove the usefulness of echocardiography in both selection of patients for CRT and identification of non-responders. On the contrary smaller trials from centres where there is high expertise in echo techniques have demonstrated that mechanical dyssynchrony can be assessed by echocardiography and can actually predict the response to CRT in a better way than traditional ECG criteria. In this manuscript, we have analysed current evidence from published data and attempted to provide insight to the field of cardiac dyssynchrony as assessed with echocardiography.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–53.
Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier AR, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol. 2003;42:2109–16.
Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873–80.
Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003;42:1454–9.
Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685–94.
Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50.
Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49.
Otto A. The role of echocardiography in quantification of left ventricular dyssynchrony: state of the art and future directions. Eur Heart J Cardiovasc Imaging. 2012;13:61–8.
Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281–329.
Bax JJ, Gorcsan III J. Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective. J Am Coll Cardiol. 2009;53:1933–43.
Bleeker GB, Schalij MJ, Molhoek SG, Verwey HF, Holman ER, Boersma E, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol. 2004;15:544–9.
Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol. 2002;39:194–201.
Yu CM, Lin H, Zhang Q, Sanderson JE. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart. 2003;89:54–60.
Chung E, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117:2608–16.
van Bommel RJ, Bax JJ, Abraham WT, et al. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J. 2009;30(20):2470–7.
Kapetanakis S, Bhan A, Murgatroyd F, et al. Real-time 3D echo in patient selection for cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2011;4(1):16–26.
Auger D, Bertini M, Marsan NA, et al. Prediction of response to cardiac resynchronization therapy combining two different three-dimensional analyses of left ventricular dyssynchrony. Am J Cardiol. 2011;108(5):711–7.
Szulik M, Tillekaerts M, Vangeel V, et al. Assessment of apical rocking: a new, integrative approach for selection of candidates for cardiac resynchronization therapy. Eur J Echocardiogr. 2010;11(10):863–9.
Stankovic I, Aarones M, Smith H-J, et al. Dynamic relationship of left-ventricular dyssynchrony and contractile reserve in patients undergoing cardiac resynchronization therapy. Eur Heart J. 2014;35(1):48–55.
Auger D, Bleeker GB, Bertini M, et al. Effect of cardiac resynchronization therapy in patients without left intraventricular dyssynchrony. Eur Heart J. 2012;33(7):913–20. This study suggests that CRT induced LV dyssynchrony in patients without baseline dyssynchrony may carry adverse outcome.
Cazeau SJ, Daubert J-C, Tavazzi L, Frohlig G, Paul V. Responders to cardiac resynchronization therapy with narrow or intermediate QRS complexes identified by simple echocardiographic indices of dyssynchrony: the DESIRE study. Eur J Heart Fail. 2008;10(3):273–80.
Beshai JF, Grimm R, Nagueh SF, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007;357(24):2461–71.
Yu C-M, Chan Y-S, Zhang Q, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol. 2006;48(11):2251–7.
Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2013;369:1395–405. Recent large multi-centre trial demonstrating that CRT in patients with narrow QRS who exhibit LV dyssynchrony on echocardiography is not beneficial and may carry unfavourable outcome.
Muto C, Solimene F, Gallo P, et al. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study. Circ Arrhythm Electrophysiol. 2013;6(3):538–45. Recent multi-centre trial which demonstrates that CRT in patients with narrow QRS and evidence of dyssynchrony is beneficial.
Auger D, Hoke U, Thijssen J, et al. Effect of cardiac resynchronization therapy on the sequence of mechanical activation assessed by two-dimensional radial strain imaging. Am J Cardiol. 2014;113(6):982–7.
Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol. 2012;59(17):1509–18.
Saba S, Marek J, Schwartzman D. Ventricular lead placement for cardiac resynchronization therapy results of the speckle tracking assisted resynchronization therapy for electrode region trial. Circ Heart Fail. 2013;6(3):427–34.
Smiseth O, Russell K, Skulstad H. The role of echocardiography in quantification of left ventricular dyssynchrony: state of the art and future directions. Eur Heart J Cardiovasc Imaging. 2012;13(1):61–8.
Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart failure events. N Engl J Med. 2009;361:1329–38.
Acknowledgements
The authors would like to thank Elsevier, Oxford University Press, the European Society of Cardiology, the American College of Cardiology Foundation and the authors Otto Armin Smiseth and Jens-Uwe Voigt for kindly giving permission to reproduce material from previously published articles.
Dr. Alexandros Papachristidis reviewed the literature and wrote the manuscript. Prof. Mark J Monaghan revised the manuscript and provided expert opinion throughout.
Compliance with Ethics Guidelines
ᅟ
Conflict of Interest
Prof. Mark J Monaghan has been granted research software from TomTec Imaging Systems GmbH and Speaker’s bureau for Koninklijke Philips N.V.
Dr. Alexandros Papachristidis' post was funded by Medtronic, Inc.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Echocardiography
Rights and permissions
About this article
Cite this article
Papachristidis, A., Monaghan, M.J. Echocardiographic Assessment of Cardiac Dyssynchrony. Where do We Stand?. Curr Cardiovasc Imaging Rep 7, 9300 (2014). https://doi.org/10.1007/s12410-014-9300-2
Published:
DOI: https://doi.org/10.1007/s12410-014-9300-2